In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs
In Brief: McDonald, Coolidge Lead ACS; Medals Awarded To Rosenberg, Boutwell, LeMaistre
FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism
Patient Satisfaction Was Crucial In ODAC Review Of Panretin
NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
